Research

Elsevier,

Understanding Autism: Perspectives, Assessment, Interventions, and the Journey Towards Inclusion, 2025, Pages 91-107

This content aligns with Goal 3: Good Health by discuss efficient care pathways including the optimal referral and assessment process, helpful interventions and gaps in the evidence base, and successful coordination between different mental health teams and other agencies.
Elsevier,

Technological Pathways for Africa' s Net-Zero Economy, Technology Solutions to Unlock Africa's Sustainable Future, 2025, Pages 217-235

This chapter advances Goal 13 by educating politicians, industry experts, and researchers on the significance of shifting toward sustainable energy solutions by offering a thorough examination of essential elements and discussing possible obstacles.

Elsevier,

Nexus, Volume 1, Issue 3, September 2024

Focusing on carbon capture, utilization, and storage (CCUS) technologies, this piece underscores their significance in realizing sustainability and carbon neutrality goals, particularly within challenging sectors.

Elsevier,

Steroids, Volume 209, September 2024

Steroidal alkaloids from bioactive sources as a potential therapeutic approach to managing Alzheimer’s. It is a review, but I think it shines a really unique light in underexplored, and oft inexpensive, approaches.
Elsevier,

Pharmacological Research - Modern Chinese Medicine, Volume 12, September 2024

The study investigates the neuroprotective effects of hordenine against AlCl3-induced Alzheimer’s disease in rats. Results show that hordenine improves memory and cognitive functions, suggesting its potential to reverse oxidative stress and neuroinflammation associated with Alzheimer’s
Elsevier,

Journal for Nurse Practitioners, Volume 20, September 2024

Nurse practitioners and other health care providers can play a crucial role in implementing chronic disease management strategies and educating patients who are at risk for AD among African Americans and Hispanics.
Elsevier,

Brain Research, Volume 1838, 1 September 2024

The study demonstrates that the peptide PHDP5, which inhibits dynamin-MT interaction, can rescue impaired endocytosis and synaptic transmission caused by tau in presynaptic terminals. When administered intranasally to Alzheimer's disease (AD) model mice, PHDP5 significantly improved learning and memory, suggesting its potential as a candidate for human AD therapy.
Elsevier,

Journal of Neuroscience Methods, Volume 409, September 2024

Despite significant investment, effective treatments for Alzheimer's disease (AD) have been elusive, necessitating improved quality and reproducibility of foundational laboratory evidence; to address this, AD-SOLES, an integrated workflow of automated tools and a publicly accessible interactive dashboard, has been developed to collect, curate, and visualize in vivo experimental evidence, enhancing evidence synthesis, tracking reporting quality, and aiding researchers in locating relevant data.
Elsevier,

iScience, Volume 27, 20 September 2024

In this study, the authors estimate the causal effect of air pollution on eye and ear health. They find that eye or ear disease possibility rises 1.48% for a 10 μg/m3 increase in four-week average PM2.5 concentration. The impacts can last about 28 weeks and will be insignificant afterward.
Elsevier,

Energy Transport Infrastructure for a Decarbonized Economy, 2025, Pages 329-372

The transport of hydrogen and hydrogen carriers aligns with sustainability and the UN SDGs by reducing greenhouse gas emissions and promoting energy efficiency, contributing to goals related to clean energy and climate action. Additionally, it creates economic opportunities, fosters innovation, and enhances energy security, supporting goals related to economic growth and infrastructure development.

Pages